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Abstract: 
 
Prostate cancer (PCa) is the leading malignancy among men. Importantly, this disease is mostly 
diagnosed at early stages offering a unique chemoprevention opportunity. Therefore, there is an 
urgent need to identify and target signaling molecules with higher expression/activity in prostate 
tumors and play critical role in PCa growth and progression. Here we report that NADPH 
oxidase (NOX) expression is directly associated with PCa progression in TRAMP mice, 
suggesting NOX as a potential chemoprevention target in controlling PCa. Accordingly, we 
assessed whether NOX activity in PCa cells could be inhibited by Graviola pulp extract (GPE) 
that contains unique acetogenins with strong anti-cancer effects. GPE (1–5 μg/ml) treatment 
strongly inhibited the hypoxia-induced NOX activity in PCa cells (LNCaP, 22Rv1 and PC3) 
associated with a decrease in the expression of NOX catalytic and regulatory sub-units (NOX1, 
NOX2 and p47phox). Furthermore, GPE-mediated NOX inhibition was associated with a strong 
decrease in nuclear HIF-1α levels as well as reduction in the proliferative and clonogenic 
potential of PCa cells. More importantly, GPE treatment neither inhibited NOX activity nor 
showed any cytotoxicity against non-neoplastic prostate epithelial PWR-1E cells. Overall, these 
results suggest that GPE could be useful in the prevention of PCa progression via inhibiting 
NOX activity. 
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Graviola inhibits hypoxia-induced 
NADPH oxidase activity in 
prostate cancer cells reducing their 
proliferation and clonogenicity
Gagan Deep1,2, Rahul Kumar1, Anil K. Jain1, Deepanshi Dhar1, Gati K. Panigrahi1, 
Anowar Hussain1,3, Chapla Agarwal1,2, Tamam El-Elimat4, Vincent P. Sica4, 
Nicholas H. Oberlies4 & Rajesh Agarwal1,2
Prostate cancer (PCa) is the leading malignancy among men. Importantly, this disease is mostly 
diagnosed at early stages offering a unique chemoprevention opportunity. Therefore, there is an 
urgent need to identify and target signaling molecules with higher expression/activity in prostate 
tumors and play critical role in PCa growth and progression. Here we report that NADPH oxidase (NOX) 
expression is directly associated with PCa progression in TRAMP mice, suggesting NOX as a potential 
chemoprevention target in controlling PCa. Accordingly, we assessed whether NOX activity in PCa 
cells could be inhibited by Graviola pulp extract (GPE) that contains unique acetogenins with strong 
anti-cancer effects. GPE (1–5 μg/ml) treatment strongly inhibited the hypoxia-induced NOX activity 
in PCa cells (LNCaP, 22Rv1 and PC3) associated with a decrease in the expression of NOX catalytic 
and regulatory sub-units (NOX1, NOX2 and p47phox). Furthermore, GPE-mediated NOX inhibition was 
associated with a strong decrease in nuclear HIF-1α levels as well as reduction in the proliferative and 
clonogenic potential of PCa cells. More importantly, GPE treatment neither inhibited NOX activity nor 
showed any cytotoxicity against non-neoplastic prostate epithelial PWR-1E cells. Overall, these results 
suggest that GPE could be useful in the prevention of PCa progression via inhibiting NOX activity.
Prostate cancer (PCa) is the most common non-cutaneous cancer in men, and according to the American Cancer 
Society reports, 220,800 new cases and 27,540 deaths from PCa were estimated in the United States in 20151. 
Fortunately, this disease is mostly diagnosed when it is still localized in the prostate and surrounding organs, 
and usually it takes a decade or more for the disease to progress to advanced adenocarcinoma and metastatic 
stages. This long latency-period offers a unique window of opportunity to prevent, inhibit and/or reverse the PCa 
growth and progression. Recent studies have suggested that one critical element in PCa growth and progression 
is the aberrant activation of NADPH oxidase (NOX)2–8. The NOX system consists of catalytic subunits (gp91phox 
[NOX1-5] and p22phox) on the membrane and regulatory subunits (p47phox, p67phox, p40phox and Rac1/2) towards 
the cytoplasm side. The NOX system passes an electron to oxygen and generates superoxide which is rapidly 
converted to hydrogen peroxide and causes oxidation of redox-sensitive cysteine residues in target molecules. 
NOX-generated reactive oxygen species (ROS) act as a secondary messenger and is involved in the regulation of 
several mitogenic and survival signaling pathways2–4,8. Importantly, dysregulated NOX-dependent ROS genera-
tion is associated with several chronic diseases, including cancer, hypertension, atherosclerosis, diabetic nephrop-
athy, and Alzheimer’s9,10. For example, NOX-mediated ROS generation activates several oncogenes (e.g. receptor 
tyrosine kinases, Src, and Ras) as well as inactivates several tumor suppressor genes (e.g. PTEN, p53, TSC2)7, 
and is considered critical in cell transformation as well as an essential element in the maintenance of malignant 
and resistant phenotype in cancer cells2,3,5,7,10–12. In this regard, NOX expression is specifically increased in PCa 
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cells, while it is absent or only transiently expressed in normal noncancerous cells; and NOX inhibition (by using 
chemical inhibitors or small interfering RNAs) retards PCa cells proliferation, invasiveness, androgen independ-
ence and angiogenesis, and induces apoptotic death via compromising multiple mitogenic/survival signaling 
pathways2–5,7,8,10,13–15.
Several genetic and epigenetic factors (e.g. oncogenic Ras, hypoxia, IFN-γ , 25-dihydroxy vitamin D3, Toll-like 
receptor ligand) are known to activate the NOX system10,16,17. Among these factors, hypoxia (low oxygen con-
dition) is one of the key elements that activates NOX, and in turn, NOX stabilizes and activates HIF-1α in a 
feed-forward mechanism7,10,16–19. In response to intermittent hypoxia, HIF1α increases the NOX2 expression in 
the central and peripheral nervous system of mice as well as in cultured cells17. Chromatin immunoprecipitation 
(CHIP) has identified HIF-1α binding to NOX4 gene, and NOX4 induction contributes to maintain ROS levels 
under hypoxia and supports proliferation of pulmonary artery smooth-muscle cells16. Block et al. have reported 
that NOX oxidase (1 and 4) and p22phox regulate HIF-2α expression in VHL-deficient renal cell carcinoma18. 
Others and we have also reported that hypoxia determines PCa aggressiveness, and is an independent prog-
nostic indicator of poor outcomes in PCa20–23. Together, this background provides a strong rationale to target 
hypoxia-induced NOX activity to prevent and treat PCa.
Graviola (Annona muricata L, Family: Annonaceae; popular common names: soursop, custard apple, guana-
bana) is an evergreen tree widely grown and consumed around the world24. Graviola pulp is consumed as juice, in 
smoothies and for the flavoring of ice cream. Graviola has also long been used in traditional medicine systems for 
benefits against bacterial and fungal infections, fever, digestive problems, high blood pressure, etc. In two earlier 
published studies, Graviola fruit powder and leaf/stem powder have shown in vitro and in vivo anti-cancer effi-
cacy against breast and pancreatic cancer cells, respectively25,26; however, this is the first study to test Graviola pulp 
extract (GPE) for its NOX inhibitory efficacy. We rationalized the testing of GPE, as Graviola fruit pulp is the part 
consumed by humans for centuries. Moreover, for future applications it will be practical and straight forward to 
translate its beneficial effects into clinic. Results showed a strong inhibitory effect of GPE on NOX activity in PCa 
cells, reducing their proliferation and clonogenic potential, but without any cytotoxicity towards non-neoplastic 
prostate epithelial cells.
Results
NOX1 and p67phox expression is associated with disease stage and aggressiveness in TRAMP 
(Transgenic adenocarcinoma of the mouse prostate) prostate tissue. TRAMP mice spontaneously 
exhibit different stages of PCa including low-grade prostate intra-epithelial neoplasia (LGPIN), high-grade PIN 
(HGPIN), and adenocarcinoma [well-differentiated (WD), moderately differentiated (MD) and poorly differ-
entiated (PD)]27,28. We first analyzed the NOX1 and p67phox expression in different stages of the disease. Results 
showed that both NOX1 and p67phox expression are either absent or extremely low in the normal prostate tissue in 
non-transgenic mice, but their expression increased with the disease progression from PIN to adenocarcinoma 
in TRAMP prostate tissue (Fig. 1A,B). These results suggested that NOX could be an important target to prevent 
PCa progression.
Comparison of various parts of Graviola for cytotoxicity against PCa cells. In earlier studies, sev-
eral commercial preparations of Graviola had been tested for their anti-cancer effects25,26,29. For standardization 
purposes, we started with various Graviola plant parts (seeds D1, pulp D2, exocarp D3, leaves D4, and twigs D5), 
prepared their extracts, and compared their cytotoxicity against human PCa cells. LNCaP and PC3 cells were 
treated with equal amounts (25 and 50 μg/ml) of these extracts (D1–D5) for 48 h, and total and dead cell num-
bers were determined by trypan blue exclusion assay. As shown in Fig. 2A, all the 5 extracts showed quite similar 
dose-dependent effect in terms of a decrease in total cell number and an increase in percentage cell death in 
LNCaP cells. In PC3 cells too, all the extracts showed cytotoxicity, with the seed extract (D1) displaying the high-
est relative efficacy (Fig. 2B). Overall, seed extract showed highest efficacy against PCa cells. However, Graviola 
pulp extract (GPE) (D2) was selected for subsequent studies with the rationale that Graviola pulp is the only part 
that is widely consumed by humans, and therefore, it has the greatest potential for translation to chemoprevention 
in humans.
GPE inhibits hypoxia-induced NOX activity in human PCa cells. As mentioned above, NOX is a 
major regulator of PCa growth and progression, so next we determined GPE efficacy to inhibit NOX activity in 
PCa cells. First, we compared the NOX activity under normoxic (21% O2) and hypoxic (1% O2) conditions in PCa 
cells. In all the three PCa cell lines, compared to normoxic condition, NOX activity was induced under hypoxic 
condition by 7-, 10- and 4- folds in 22Rv1, LNCaP and PC3 cells, respectively (Fig. 3A–C). GPE treatment (1, 2.5 
and 5 μg/ml) significantly inhibited the hypoxia-induced NOX activity in 22Rv1 cells by 39–98%, LNCaP cells by 
77–91% and in PC3 cells by 71–75% (Fig. 3A–C). Importantly, NOX activity was extremely low in non-neoplastic 
prostate epithelial PWR-1E cells and was not affected following GPE treatment (1–5 μg/ml; data not shown). In 
addition, we also assessed the direct effect of GPE on NOX activity by incubating cellular homogenates with GPE 
(1–5 μg/ml). As shown in Fig. 3D, GPE could also directly inhibit NOX activity in LNCaP cells; and we had simi-
lar results in 22Rv1 cells (data not shown).
GPE decreases the expression of various subunits of NOX system and HIF-1α/ HIF-2α tran-
scription factor in human PCa 22Rv1 cells under normoxic and hypoxic conditions. We selected 
22Rv1 cells to elucidate the mechanism associated with GPE-mediated inhibition of NOX activity by evaluating 
the expression of various subunits of NOX system at the mRNA level by semi-quantitative RT-PCR. Results 
showed that GPE slightly decreased the expression of NOX1 only under hypoxic conditions, but decreased the 
expression of p47phox under both normoxic and hypoxic conditions (Fig. 4A). Further, we evaluated the mRNA 
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expression of HIF-1α transcription factor in 22Rv1 cells, and the results showed that there was no change in the 
expression of HIF-1α mRNA levels (Fig. 4A). The literature suggests that the regulatory subunits of the NOX 
system (p67phox and p47phox) are primarily cytosolic that translocate to the cellular membrane following different 
stimuli (e.g. hypoxia) to activate the catalytic subunits (gp91phox). Accordingly, next we assessed the effect of GPE 
on the cytosolic and membrane level of NOX1, NOX2, p67phox and p47phox under hypoxic conditions. Results 
showed that there was no significant change in NOX1 and NOX2 level in the cytoplasmic fraction, while only 
NOX2 level decreased in the membrane fraction following GPE treatment (Fig. 4B). The level of p67phox and 
p47phox decreased in both the fractions, but a relatively lower amount of p67phox was detected in the membrane 
fraction (Fig. 4B).
As mentioned above, under hypoxic conditions, NOX and HIF-1α reciprocate and control each other’s 
expression at various levels. Therefore, we subsequently evaluated the effect of GPE treatment on HIF-1α expres-
sion via immunoblotting in 22Rv1 cells. As expected, compared to normoxia, under hypoxia, HIF-1α protein 
expression was strongly increased, and that was strongly inhibited by GPE treatment (Fig. 4C). To confirm 
that GPE-mediated NOX inhibition was involved in the decreased HIF-1α expression, we also used the NOX 
Figure 1. NOX expression is associated with disease progression in TRAMP mice. (A,B) NOX1 and p67phox 
expression was analyzed by IHC in TRAMP prostate tissue with different stages of the disease as well as in 
non-transgenic mice prostate tissue as negative control. Representative photographs are presented at 100x; 
inset represent further magnification of a part of the photograph. Immunoreactivity (represented by brown 
staining) of NOX1 and p67phox was scored as described in methods. Abbreviations: NC: Negative control; LG: 
Low-grade; HG: High-grade; PIN: Prostate intra-epithelial neoplasia; WD: Well differentiated; MD: Moderately 
differentiated; PD: Poorly differentiated. *p ≤ 0.001.
www.nature.com/scientificreports/
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inhibitor diphenyleneiodonium chloride (DPI; 20 μM) in this experiment. As shown in Fig. 4C, DPI treatment 
completely inhibited the hypoxia-induced HIF-1α expression in 22Rv1 cells. We did not observe any significant 
change in HIF-1β expression in 22Rv1 under hypoxic conditions as well as following GPE treatment, which is 
expected as HIF-1β is constitutively expressed in these cells. Compared to HIF-1α , we observed extremely low 
level of HIF-2α in 22Rv1 cells under hypoxic conditions which was strongly decreased by DPI and GPE treat-
ment (Fig. 4C). Next, we prepared nuclear and cytoplasmic fraction to characterize the effect of GPE treatment 
on the sub-cellular localization of HIF-1α and HIF-2α . As shown in Fig. 4D, HIF-1α was localized primarily in 
the nucleus, and its expression was strongly inhibited by GPE treatment. Similarly, HIF-2α expression (extremely 
low) was only in the nucleus, which was completely inhibited by GPE treatment (data not shown). These results 
suggest that enhancement in NOX activity is an important event under hypoxic conditions, which directly/indi-
rectly regulates stabilization of HIF-1α expression in PCa cells.
GPE inhibits the clonogenicity of human PCa cells under normoxic and hypoxic condi-
tions. Earlier studies have shown that NOX activity inhibition results in a reduction in the survival of cancer 
cells2,3,8,30; therefore, next we determined the effect of GPE treatment on the colony forming potential of PCa 
cells in the clonogenic assay. As shown in Fig. 5A, GPE treatment (1–5 μg/ml) almost completely inhibited the 
clone formation by 22Rv1 cells under both normoxic and hypoxic conditions. Similarly, GPE treatment reduced 
the clonogenic potential of PC3 cells under both normoxic (by 30–56%) and hypoxic (by 35–55%) conditions 
in a dose-dependent manner (Fig. 5B); however, GPE efficacy was not as prominent in PC3 cells compared with 
22Rv1 cells. This could probably be due to the genetic differences between the two cells lines where 22Rv1 cells 
express androgen receptor (mutated but functional), p53 and PTEN while PC3 cells lack androgen receptor, p53 
and PTEN expression.
GPE specifically reduces cell viability of human PCa cells under normoxic and hypoxic condi-
tions. Next, the effect of GPE treatment (2.5, 5, 10 and 20 μg/ml) for 24–48 h was examined in three human 
PCa cell lines by trypan blue exclusion assay under both normoxic and hypoxic conditions. As shown in 
Fig. 6A,B, GPE treatment caused a significant decrease in total cell number and an increase in cell death in all 
the three PCa cell lines under both normoxic and hypoxic conditions. We also assessed the cytotoxicity of GPE 
treatment on non-neoplastic prostate epithelial PWR-1E cells by trypan blue exclusion assay. As shown in Fig. 6A, 
no significant change was observed in total cell number as well as percentage cell death following GPE treatment 
Figure 2. Comparison of various parts of Graviola for cytotoxicity against PCa cells. (A,B) LNCaP and PC3 
cells were seeded at the density of 5 × 104 cells/well in 6-well plates. After 24 h of seeding, cells were treated with 
25 and 50 μg/ml concentrations of Graviola extracts (D1: seeds extract; D2: pulp extract; D3: exocarp extract; 
D4: leaves extract; D5: twigs extract) for 48 h. At the end of 48 h, cells were harvested and counted as mentioned 
in ‘Materials and Methods’, and total cell number and percentage of dead cells are presented as mean ± SEM. 
*p ≤ 0.001; #p ≤ 0.01.
www.nature.com/scientificreports/
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(2.5–20 μg/ml) in PWR-1E cells. These results clearly indicate the specific cytotoxicity of GPE against PCa cells 
with no cytotoxic effect against non-neoplastic prostate epithelial cells.
Characterization of GPE. In the direction of characterizing the active constituents in GPE, the sam-
ple was subjected to ultraperformance liquid chromatography–high resolution tandem mass spectrometry 
(UPLC-HRMS-MS/MS) (Fig. 7). As reported previously, to increase the sensitivity of the MS/MS fragments for 
acetogenins, lithium fluoride was infused post-column to form [M+ Li]+ adducts31. Furthermore, higher‒energy 
collision dissociation (HCD) was used, as it affords high resolution fragmentation, thus facilitating the elucidation 
of the structural backbone. Fragmentation typically occurs on either side of the hydroxy groups, and this pattern 
assists in identifying the placement of the tetrahydrofuran ring along the hydrocarbon chain in relationship to the 
lactone ring (Fig. 8) as well as the placement of any ancillary hydroxy groups. These patterns were compared to 
those reported in literature to tentatively identify the structures of the acetogenins31–33.
Discussion
PCa is the leading cause of cancer-related incidences and 2nd leading cause of cancer-related deaths in the United 
States. Increasingly, we have succeeded in early diagnosis of the disease localized mostly at the PIN stage; how-
ever, this has not translated into reducing PCa morbidity and mortality. Newly diagnosed PCa patient are mostly 
kept on watchful waiting and monitored for years as the potential challenges with the treatment exceeds the ben-
efits. These PCa patient populations could be ideal for chemopreventive approaches, as such agents are generally 
Figure 3. GPE inhibits NOX activity in human PCa cells. (A–C) Human PCa 22Rv1, LNCaP and PC3 cells 
were seeded at the density of 4 × 105 cells/60 mm culture dishes. After 24 h of seeding, cells were treated with 1, 
2.5 and 5 μg/ml concentrations of GPE under hypoxic condition (1% O2) for 24 h. In each case, cells cultured 
under normoxic condition (21% O2) served as relevant control. At the end of 24 h, cells were harvested and 
NOX activity was measured as mentioned in ‘Materials and Methods’ and represented as rlu/mg protein.  
(D) Direct inhibition of NOX activity by GPE was assessed by pre-incubating GPE (1.0–5.0 μg/ml) with cellular 
homogenates and NOX activity was measured as mentioned in ‘Materials and Methods’ and represented as 
rlu/mg protein. Each value represents mean ± SEM of three samples for each treatment. $p ≤ 0.05; #p ≤ 0.01; 
*p ≤ 0.001.
www.nature.com/scientificreports/
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Figure 4. GPE inhibits the expression of members of NOX system and HIF-1α in human PCa 22Rv1 cells. 
(A) 22Rv1 cells were treated with GPE (1–10 μg/ml) under normoxic (21% O2) or hypoxic (1% O2) conditions 
for 24 h. Thereafter, cells were collected and analyzed for mRNA expression of NOX1, p47phox and HIF-1α by 
RT-PCR using gene specific primers as mentioned in ‘Materials and Methods’. β -actin served as an endogenous 
internal standard. (B) 22Rv1 cells were treated with GPE (1–5 μg/ml) under hypoxic (1% O2) condition for 24 h. 
Thereafter, cells were collected and cytosolic and membrane fractions were prepared and analyzed for levels of 
NOX1, NOX2, p67phox and p47phox by immunoblotting. β -actin and E-cadherin were used to check the purity 
of cytoplasmic and membrane fractions as well as for loading control. Densitometry data presented below the 
bands are ‘fold change’ as compared with control (DMSO treated) after normalization with respective loading 
control. (C) 22Rv1 cells were treated with DPI (20 μM) and GPE (10 and 20 μg/ml) under hypoxic (1% O2) 
condition for 6 h. Cells cultured under normoxic condition (21% O2) served as relevant control. Thereafter, 
cells were collected and total cell lysates were prepared and analyzed for HIF-1α , HIF-1β , HIF-2α and tubulin. 
Densitometry data presented below the bands are ‘fold change’ as compared with hypoxia control (DMSO 
treated) after normalization with respective loading control. (D) 22Rv1 cells were treated with GPE (10 and 
20 μg/ml) under hypoxic (1% O2) condition for 6 h. Cells cultured under normoxic condition (21% O2)  
served as relevant control. Thereafter, cells were collected and nuclear/cytoplasmic fractions were prepared 
and analyzed for HIF-1α expression. Membranes were also probed for TBP and tubulin as loading control 
for nuclear and membrane fractions, respectively. Densitometry data presented below the bands are ‘fold 
change’ as compared with hypoxia control (DMSO treated) after normalization with respective loading control. 
Abbreviations: N: Normoxic; H: Hypoxic; GPE: Graviola pulp extract; DPI: Diphenyleneiodonium.
www.nature.com/scientificreports/
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non-toxic, orally bioavailable, and have broad efficacy. However, the main challenges in PCa chemoprevention 
approaches are reliable biomarkers for predicting the course of disease, as well as, the efficacy of the chemopre-
ventive agents.
Accumulating evidences clearly indicates that NOX activity could affect several of the hallmarks of cancer, 
including genomic instability, growth, survival, angiogenesis, invasion and metastasis2,3,5,7,10. There are abundant 
reports suggesting that the NOX system plays an important role in PCa growth and progression2–5,8,30. In a pioneer 
study, Arbiser et al. showed that ectopic expression of NOX1 in PCa cells promoted their growth, tumorigenicity 
and angiogenicity5. Lim et al. reported that NOX1 is overexpressed in a high percentage of human prostate tum-
ors associated with elevated ROS generation4. That study also reported that increased NOX protein correlated 
with enhanced tumor and metastatic potential of PCa cells4. Similarly, NOX5 down-regulation caused growth 
arrest and apoptosis in PCa cells30. Another study by Kumar et al. clearly established that NOX-mediated oxida-
tive stress determines PCa aggressiveness2. Importantly, NOX (1, 2 and 4) expression is significantly up-regulated 
in rat ventral prostate following castration6. In the present study, we identified that NOX1 and p67phox expression 
is associated with PCa progression in TRAMP mice. Together, these studies provide a strong support towards the 
development of non-toxic NOX inhibitors in the prevention and treatment of PCa.
Based upon this rationale, several NOX inhibitors (e.g. apocynin, diphenylene iodonium, 4-[2-aminoethyl]-be
nzensulfonylfluorid, VAS2870, and VAS3947) have been tested for their anti-cancer efficacy34. However, most 
of the existing NOX inhibitors lack specificity, and high concentrations are needed to exert their biological 
effects15,34,35. In the present study, we identified that Graviola pulp extract (GPE) could effectively inhibit NOX 
activity in PCa cells at low concentrations (≥ 1 μg/ml) together with strong reduction in PCa cell proliferation 
and clonogenicity. This is exciting since Graviola pulp is extensively consumed by humans around the world, and 
therefore, any confirmed benefits could be easily translated for human use.
The idea of testing Graviola for anticancer effects is primarily rooted in the presence of Annonaceous ace-
togenins (derivatives of long chain C35–C37 fatty acid biosynthesized via the polyketide pathway) in its various 
parts (leaves, stem, pulp, seeds etc). Several of these acetogenins exert cytotoxicity via inhibiting mitochondrial 
complex I that is involved in ATP synthesis36. Based upon that, it was rationalized that acetogenins could spe-
cifically inhibit growth of cancer cells that usually have a higher demand for ATP compared to normal cells36,37. 
In this regard, Torres et al. recently showed that Graviola leaf/stem extract decreases ATP content in pancreatic 
Figure 5. GPE inhibits the clonogenicity of human PCa cells under normoxic and hypoxic conditions. 
(A,B) Human PCa 22Rv1 and PC3 cells (~1 × 103 cells per well) were cultured in 6-well plates and treated 
with GPE (1–5 μg/ml) under normoxic (21% O2) or hypoxic (1% O2) conditions for 48 hrs. Thereafter, cells 
were maintained under normoxic conditions and clones were counted after 7 days. Each value represents 
mean ± SEM of three samples for each treatment. #p ≤ 0.01; *p ≤ 0.001.
www.nature.com/scientificreports/
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cancer cells; however, that study did not test Graviola effect on normal pancreatic cells26. Furthermore, that study 
showed that Graviola targeted multiple pathways that regulate metabolism, cell cycle, survival and metastasis of 
pancreatic cancer cells26. Graviola treatment also affected the expression of molecules related to hypoxia and glyc-
olysis (HIF-1α , NF-κ B, GLUT1, GLUT4, hexokinase II and lactate dehydrogenase-A) in pancreatic cancer cells26. 
In another study, Dai et al. reported that Graviola fruit extract selectively inhibits the growth of human breast 
cancer cells both in vitro and in vivo via down-regulation of EGFR expression25. Importantly, higher expression 
of NOX subunits have also been reported in several cancers, including those of the pancreas and breast7. There is 
a possibility that the reported efficacy of Graviola extracts against pancreatic and breast cancer is through NOX 
inhibition.
Our rationale of testing the Graviola pulp extract for NOX activity inhibition was based upon an earlier study, 
where a specific annonaceous acetogenin, bullatacin, showed the capability to inhibit NOX activity in HeLa and 
HL-60 cells38. We still need to confirm the presence of bullatacin, or more likely, structurally related analogues, 
to identify acetogenins in GPE that could inhibit NOX activity. Past studies on the chemistry of annonaceous 
Figure 6. GPE reduces cell viability of human PCa cells under normoxic and hypoxic conditions.  
(A,B) 22Rv1, LNCaP, PC3 and PWR-1E cells were seeded at the density of 5 × 104 cells/well in six well plates. 
After 24 h of seeding, cells were treated with 2.5–20 μg/ml concentrations of GPE under normoxic (21% O2) or 
hypoxic (1% O2) conditions for 24 and 48 h. At the end of each time point, cells were harvested and counted as 
mentioned in ‘Materials and Methods’, and total cell number and percentage of dead cells are shown. Each value 
represents mean ± SEM of three samples for each treatment. $p ≤ 0.05; #p ≤ 0.01; *p ≤ 0.001.
www.nature.com/scientificreports/
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acetogenins impart an obvious starting point for the full characterization of GPE29,39. Moreover, recent develop-
ments in chromatography and mass spectrometry will enable this task to be completed rapidly and in a reproduc-
ible manner on a wide array of substrates, from foods to juices to dietary supplements31. Such chemical analysis 
will be helpful in establishing the amount of bioactive acetogenins consumed by humans in the form of dietary 
supplements, juices or as food. Pharmacology studies will also be needed to correlate those chemical profiles to 
ascertain the best combination for targeting NOX activity in cancer cells, particularly in vivo. Furthermore, we 
need to examine whether GPE could also target mitochondrial complex I and ATP production in PCa cells, and 
these effects contribute to its strong anti-PCa efficacy independent of NOX activity inhibition.
Figure 7. Chemical characterization of GPE. Sample was analyzed as detailed in the methods. (A) The total 
ion chromatogram of the GPE. (B) The extracted ion chromatograms, detailed to the right, overlaid with each 
other. The color coding subdivides the acetogenins based upon their molecular ions.
Figure 8. Example characterization of acetogenins. The MS/MS spectrum of the peak at 4.58 min (coded blue 
in Fig. 7). These data illustrate the common fragmentation patterns observed with acetogenins. In particular, 
note the fragments adjacent to hydroxy moieties, thereby facilitating the elucidation of the positioning of 
the THF ring and each hydroxy group. Based on these data and the associated literature, this compound is 
tentatively identified as annonacin.
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Overall, the present study for the first time showed that GPE is a novel NOX inhibitor and possesses strong 
efficacy against PCa. Since Graviola pulp is widely consumed by humans and is non-toxic, it could be readily 
developed for chemoprevention use in normal/high risk individuals as well as for intervention in PCa patients.
Materials and Methods
Cell culture and reagents. Human prostate carcinoma 22Rv1, LNCaP, PC3 and non-neoplastic immortal-
ized PWR-1E cells were obtained from American Type Culture Collection (Manassas, VA). 22Rv1 and LNCaP 
cells were cultured in RPMI1640 medium supplemented with 10% fetal bovine serum (FBS), 100 U/ml penicillin 
G, and 100 μg/ml streptomycin sulfate in a humidified 5% CO2 incubator. PC3 cells were cultured in RPMI1640 
medium supplemented with 10% heat inactivated FBS, 100 U/ml penicillin G and 100 μg/ml streptomycin sulfate. 
PWR-1E cells were cultured in keratinocyte serum-free medium containing 50 μg/ml bovine pituitary extract and 
5 ng/ml epidermal growth factor; and supplemented with 10% FBS during cell viability assay. Media and other 
cell culture materials were from Invitrogen Corporation (Gaithersburg, MD). GPE stock solution (100 mg/ml) 
was prepared in DMSO and stored at − 80 °C. An equal amount of DMSO (vehicle) was present in each treatment, 
including control; DMSO concentration did not exceed 0.1% (v/v) in any treatment. Lucigenin, NADPH, sucrose, 
sodium phosphate monobasic and dibasic, Tris, EDTA, EGTA, NAC, DPI and VAS2870 were from Sigma-Aldrich 
(St Louis, MO). Antibodies for HIF-1α , HIF-1β , HIF-2α , E-cadherin, p47phox, and tubulin as well as HRP conju-
gated anti-mouse and anti-rabbit secondary antibodies were from Cell Signaling (Beverly, MA); p67phox, NOX1 
and TATA-binding protein (TBP) antibodies were from Abcam (Cambridge, MA); and NOX2 antibody was 
from Boster Biological technology (Fremont, CA). Enhanced chemiluminescence detection system was from GE 
healthcare (Buckinghamshire, UK).
Trypan blue exclusion assay. At the end of desired treatment time, cells were collected and total cell num-
ber and dead cell number were determined using a hemocytometer after trypan blue staining.
Clonogenic assay. 22Rv1 and PC3 cells (~1 × 103 cells per well) were plated in 6-well plates. Next day, 
cells were treated with DMSO or GPE (1, 2.5 and 5 μg/ml) followed by incubation under normoxic (21% O2) or 
hypoxic (1% O2) conditions for 48 h. Thereafter, cells were maintained under normoxic conditions (21% O2) with 
DMSO or fresh GPE. At the end of the 7th day, cells were washed twice with ice cold PBS, fixed with a mixture of 
methanol and glacial acetic acid (3:1) for 10 min and then stained with 1% crystal violet in methanol for 15 min 
followed by washing with deionized water. Colonies with more than 50 cells were scored and counted under the 
microscope.
NOX activity assay. Cultured cells were homogenized in lysis buffer (20 mM KH2PO4 pH 7.0, 1 mM EGTA, 
1 mM phenylmethylsulfonyl fluoride, 10 mg/ml aprotinin, and 0.5 mg/ml leupeptin) by using a Dounce homoge-
nizer (100 strokes on ice). Homogenates were centrifuged at 800 g at 4 °C for 10 min to remove the unbroken cells 
and debris. For determining NOX activity, 100 μl aliquots of homogenates were added to 900 μl of 50 mM phos-
phate buffer containing 1 mM EGTA, 150 mM sucrose, 5 mM lucigenin, and 100 mM NADPH, pH 7.0. Photon 
emission was measured in a luminometer (Promega, Madison, WI) every 1 min for 15 min. There was no measur-
able activity in the absence of NADPH. Protein concentration was determined using the DC Protein assay system 
(Bio Rad, Hercules, CA). Superoxide anion production was expressed as relative chemiluminescence (light) units 
(RLU)/mg protein. Direct effect of GPE on hypoxia-induced NOX activity was also analyzed by pre-incubating 
cellular homogenate for 10 min with 1–5 μg/ml final concentrations of GPE, and NOX activity assay was per-
formed as mentioned above.
RT-PCR. A semi-quantitative reverse transcriptase–polymerase chain reaction (RT-PCR) analysis of 
NOX1, p47phox and HIF-1α messenger RNAs (mRNAs) in 22Rv1 cells was performed using gene-specific 
primers. Total RNA was extracted from DMSO or GPE-treated 22Rv1 cells with Tri reagent (Sigma-Aldrich, 
St. Louis, MO) following the manufacturer’s instructions. Total RNA was treated with RNase-free DNase 
(Thermo Scientific, Rockford, IL) and the integrity of RNA was determined by running on agarose gel prior 
to further downstream application. The RT-PCR was carried out using one-step RT-PCR kit (Qiagen, 
Valencia, CA) according to the manufacturer’s instructions and total RNA (200 ng) was taken as template 
for each reaction. β -actin gene was taken as endogenous internal standard. NOX1 oligonucleotide sequences 
for PCR primers were 5′-GGTTGTTTGGTTAGGGCTGA-3′ and 5′-CTGGAGAGAATGGAGGCAAG-3′. 
p47phox oligonucleotide sequences for PCR primers were 5′-CCCGATACCCAGTTTCAGTG-3′ and 
5′-GGAAGGTCTCCTTGAGGGTC-3′. HIF-1α  oligonucleotide sequences for PCR primers were 
5′-CAGAGCAGGAAAAGGAGTCA-3′ and 5′-AGTAGCTGCATGATCGTCTG-3′. β -actin oligonucleotide 
sequences for PCR primers were 5′-TCCTTAATGTCACGCACGATTT-3′ and 5′-GAGCGCGGCTACAGCTT-3′.
Graviola extracts preparation and GPE chemical characterization. Samples of Annona muricata 
plant parts (i.e. seeds, pulps, exocarp, leaves, and twigs) were acquired from the Philippines via Trish Flaster of 
Botanical Liaisons (Boulder, CO), and a voucher specimen (NCU633520) was deposited in the herbarium of the 
University of North Carolina at Chapel Hill. The samples were processed using procedures described in detail 
previously40. Briefly, to each 1000 mL flask containing a sample of ~25 g of powdered plant material (where all 
parts were treated separately) 240 mL of 1:1 MeOH/CHCl3 were added. The samples were stirred overnight at 
room temperature, filtered using vacuum filtration, and the remaining residues were washed with MeOH. To the 
filtrate, 360 mL of CHCl3 and 600 mL of water were added. The mixtures were stirred for ½ h, and then transferred 
into separatory funnels. The bottom layers were drawn off into round-bottom flasks, which were evaporated to 
dryness. The dried organic extracts were re-constituted in 200 mL of 1:1 MeOH/CH3CN and 200 mL of hexanes 
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and transferred to separatory funnels. The biphasic solutions were shaken vigorously. The MeOH/CH3CN layers 
were evaporated to dryness under vacuum.
HRESIMS was performed in positive ionization mode on a Thermo Q Exactive Plus mass spectrometer 
(ThermoFisher, San Jose, CA) equipped with an electrospray ionization source. UPLC was carried out on a Waters 
Acquity system [using a BEH C18 (2.1 × 100 mm, 1.7 μm) column (Waters Corp., Massachusetts, USA) equili-
brated at 40 °C]. A mobile phase consisting of CH3CN:H2O (both acidified with 0.1% formic acid) at a flow rate 
of 300 μL/min was used for analysis with lithium fluoride (2 mM in MeOH) infused post-column at a flow rate of 
5 μL/min. The gradient started with 70:30 (CH3CN:H2O) for 1 min then increased linearly to 100% CH3CN over 
7 min, holding for 1.5 min and then returning to the starting conditions within 0.5 min. An Acquity UPLC pho-
todiode array detector was used to acquire PDA spectra, which were collected from 190–500 nm with 4 nm res-
olution. Higher-energy collisional dissociation (HCD) was performed using normalized collision energy (NCE) 
at 60%.
Immunohistochemistry (IHC). Paraffin-embedded TRAMP and non-transgenic prostate tissue sections 
from earlier completed studies were used to determine the expression of NOX1 and p67phox by IHC27,28. Briefly, 
sections were incubated with anti-NOX1 or anti-p67phox antibody, followed by a specific biotinylated secondary 
antibody (1:250 dilution), and then conjugated HRP streptavidin and DAB working solution, and counterstained 
with hematoxylin. Stained sections were analyzed by Zeiss Axioscope 2 microscope and images captured by 
AxioCam MrC5 camera at 100x magnification. Immunoreactivity (represented by brown staining) was scored as 
0+ (no staining), 1+ (weak staining), 2+ (moderate staining), 3+ (strong staining), 4+ (very strong staining).
Immunoblotting. Total cell lysates, nuclear and cytoplasmic fractions were prepared following our pub-
lished protocols41,42 and cytosolic/membrane fractions were prepared using subcellular protein fractionation kit 
(Thermo scientific, Rockford, IL) following the manufacturer’s instructions. Approximately, 40–60 μg of protein 
lysate per sample was denatured in 2× sample buffer and subjected to sodium dodecyl sulfate–polyacrylamide 
gel electrophoresis (SDS-PAGE) on Tris–glycine gel. The separated proteins were transferred on to nitrocellulose 
membrane followed by blocking with 5% non-fat milk powder (w/v) in Tris-buffered saline (10 mM Tris–HCl, 
pH 7.5, 100 mM NaCl, 0.1% Tween 20) for 1 h at room temperature. Membranes were probed for the protein 
levels of desired molecules using specific primary antibodies followed by the appropriate peroxidase-conjugated 
secondary antibody and visualized by ECL detection system. To ensure equal protein loading, membranes were 
stripped and re-probed with appropriate loading control. The bands were scanned with Adobe Photoshop 6.0 
(Adobe Systems, San Jose, CA) and band density was determined using the Image J software. In each case, blots 
were subjected to multiple exposures on the film to make sure that the band density is in the linear range.
Statistical analysis. Statistical analyses were performed with Sigma Stat software version 2.03 (Jandel scien-
tific, San Rafael, CA) and Prism 5.0 (Graphpad software, La Jolla, CA). One-way ANOVA followed by Tukey’s test 
was used for multiple comparisons and statistically significant difference was considered at p ≤ 0.05.
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